HOME    NEWSLETTER ARCHIVE    CME/CNE/CPE INFORMATION    PROGRAM DIRECTORS    EDIT PROFILE    RECOMMEND TO A COLLEAGUE

Kieren A. Marr, MD
Director
Transplant Medicine and Oncology Infectious Diseases Program
Johns Hopkins Hospital
Baltimore, Maryland

Dr. Marr’s research is focused on Aspergillus pathogenesis, and prevention
and early diagnosis of invasive mould infections in immunocompromised patients. She was trained in microbiology at California State University and subsequently investigated toxoplasmosis and EBV-associated lymphoma in laboratories at Stanford and the National Institutes of Health. She received her medical degree from Hahnemann University and completed her internship and residency in Internal Medicine at Duke University. The author of numerous original scientific papers, Dr. Marr sits on multiple editorial boards. She served on the program committee of the Infectious Diseases Society of America and the Council of the Immunocompromised Host Society and is the recipient of many prestigious awards.


Faculty Disclosure
Dr. Marr discloses that she received grant/research support from Enzon and Merck & Co., Inc. and has served as a consultant to Astellas, Basilea, Merck & Co., Pfizer Inc, and Schering-Plough.
Aruna K. Subramanian, MD
Assistant Professor of Medicine
Division of Infectious Disease
Department of Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland

The recipient of many grants, her research focuses on reducing surgical site infections, treating RSV in lung and bone marrow transplants, studying outcomes of kidney and liver transplants in stable HIV patients, and the spectrum and severity of Infectious complications in Johns Hopkins Incompatible Kidney Transplant Program (InKTP). A Diplomate of the ABIM, Subspecialty of Infectious Diseases, Dr. Subramanian is a member of IDSA and AST where she sits on the Practice Guidelines Committee and Chairs the Infectious Diseases Educational Initiatives Committee.

Faculty Disclosure
Dr. Subramanian discloses that for serving as a principal Investigator for Chimerix, she has received grant/research support. She has also served as a consultant to ViroPharma, Inc.
Michael G. Ison, MD, MS
Assistant Professor
Divisions of Infectious Diseases and Organ Transplantation
Feinberg School of Medicine
Northwestern University
Medical Director, Transplant & Immunocompromised Host
Infectious Diseases Service
Northwestern Memorial Hospital
Chicago, Illinois

Dr. Ison obtained his Master of Science in Health Evaluation Sciences while conducting his Infectious Diseases Fellowship at the University of Virginia. A part of Dr. Frederick Hayden’s research group, Dr. Ison’s initial work was with influenza and other respiratory viruses in critically ill and immunocompromised patients. He did additional training in Transplant Infectious Diseases with Jay Fishman’s group at the Massachusetts General Hospital. In his current position with the Transplant & Immunocompromised Host Infectious Diseases Service at Northwestern University, Dr. Ison has continued focusing on respiratory viral infections in immunocompromised patients.

Faculty Disclosure
Dr. Ison has discloses that he has received grant/research support for serving as a Principal Investigator for ADMA, BioCryst, Pfizer Inc, Roche, ViraCor, and ViroPharma, Inc. He has received honoraria from Abbott Molecular and ViraCor as well as other financial or material support from Chimerix.
Kenneth R. Lawrence, BS, PharmD
Assistant Professor of Medicine
Tufts University School of Medicine
Clinical Pharmacy Specialist, Infectious Disease
Department of Pharmacy
Division of Geographic Medicine and Infectious Disease
Tufts Medical Center
Boston, Massachusetts

Dr. Lawrence’s research interests include measuring the impact of antimicrobial stewardship programs and antimicrobial pharmacoeconomics. He is the Infectious Disease Clinical Pharmacy Specialist and Director of the Specialty Residency Program in Infectious Disease Pharmacy at Tufts Medical Center in Boston. Dr. Lawrence has presented at local, regional, and national scientific meeting on a wide range of infection disease and critical care topics and has published original scientific work in several peer-reviewed journals on many infectious disease topics. He graduated of University of Rhode Island with both a BS in Pharmacy and a Doctor of Pharmacy degree. He completed a Clinical Practice Residency in Pharmacy Practice at Detroit Receiving Hospital.

Faculty Disclosure
Dr. Lawrence discloses that he has received grant/research support for his role as a Principal Investigator for Merck & Co., and AstraZeneca.  Additionally, he has served as a consultant for Johnson & Johnson and is on the Speakers’ Bureaus of Astellas, Merck & Co., Pfizer Inc, and Wyeth.
Michelle Felix, RN, MSN, CPNP
Pediatric SOT Coordinator
Johns Hopkins Children’s Center
Baltimore, Maryland

Michelle Felix, RN, MSN, CRNP received her BSN and MSN from the Johns Hopkins University School of Nursing. For her undergraduate work, she was honored for her excellence in nursing and she graduated with honors from her MSN program.  Ms. Felix’s entire career has been devoted to caring for pediatric, with an emphasis in oncology. She currently serves as the pediatric solid organ transplant coordinator at The Johns Hopkins Children’s Center.

Faculty Disclosure
Ms. Felix does not have any financial relationships to disclose.
   











 

PRIVACYLEGAL DISCLAIMERCONTACT US